Answer
Breastfeeding is not recommended during dacomitinib monohydrate (Vizimpro) treatment because serious adverse reactions could occur in exposed infants, and it is unknown whether dacomitinib or its metabolites enter human milk.
Sources for this answer
- Vizimpro 15mg film-coated tabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked